Literature DB >> 21818468

Misfolded proteins in Alzheimer's disease and type II diabetes.

Alaina S DeToma1, Samer Salamekh, Ayyalusamy Ramamoorthy, Mi Hee Lim.   

Abstract

This tutorial review presents descriptions of two amyloidogenic proteins, amyloid-β (Aβ) peptides and islet amyloid polypeptide (IAPP), whose misfolding propensities are implicated in Alzheimer's disease (AD) and type II diabetes, respectively. Protein misfolding diseases share similarities, as well as some unique protein-specific traits, that could contribute to the initiation and/or development of their associated conditions. Aβ and IAPP are representative amyloidoses and are used to highlight some of the primary considerations for studying misfolded proteins associated with human diseases in this review. Among these factors, their physiological formation, aggregation, interactions with metal ions and other protein partners, and toxicity are presented. Small molecules that target and modulate the metal-Aβ interaction and neurotoxicity are included to illustrate one of the current approaches for uncovering the complexities of protein misfolding at the molecular level.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818468      PMCID: PMC3210870          DOI: 10.1039/c1cs15112f

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN: 0306-0012            Impact factor:   54.564


  102 in total

Review 1.  Protein misfolding and disease; protein refolding and therapy.

Authors:  C Soto
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  Zinc, the pancreas, and diabetes: insights from rodent studies and future directions.

Authors:  Carla G Taylor
Journal:  Biometals       Date:  2005-08       Impact factor: 2.949

Review 3.  Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.

Authors:  Vello Tõugu; Ann Tiiman; Peep Palumaa
Journal:  Metallomics       Date:  2011-02-25       Impact factor: 4.526

4.  Deaths: final data for 2008.

Authors:  Arialdi M Miniño; Sherry L Murphy; Jiaquan Xu; Kenneth D Kochanek
Journal:  Natl Vital Stat Rep       Date:  2011-12-07

5.  A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc.

Authors:  Samer Salamekh; Jeffrey R Brender; Suk-Joon Hyung; Ravi Prakash Reddy Nanga; Subramanian Vivekanandan; Brandon T Ruotolo; Ayyalusamy Ramamoorthy
Journal:  J Mol Biol       Date:  2011-05-17       Impact factor: 5.469

6.  Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.

Authors:  Jung-Suk Choi; Joseph J Braymer; Ravi P R Nanga; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-03       Impact factor: 11.205

7.  Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.

Authors:  Emma T A S Jaikaran; Melanie R Nilsson; Anne Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

8.  Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro.

Authors:  S B Chargé; E J de Koning; A Clark
Journal:  Biochemistry       Date:  1995-11-07       Impact factor: 3.162

9.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process.

Authors:  Jed J W Wiltzius; Stuart A Sievers; Michael R Sawaya; David Eisenberg
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

10.  Pleomorphic copper coordination by Alzheimer's disease amyloid-beta peptide.

Authors:  Simon C Drew; Christopher J Noble; Colin L Masters; Graeme R Hanson; Kevin J Barnham
Journal:  J Am Chem Soc       Date:  2009-01-28       Impact factor: 15.419

View more
  90 in total

1.  Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.

Authors:  Joseph J Braymer; Jung-Suk Choi; Alaina S DeToma; Chen Wang; Kisoo Nam; Jeffrey W Kampf; Ayyalusamy Ramamoorthy; Mi Hee Lim
Journal:  Inorg Chem       Date:  2011-09-28       Impact factor: 5.165

Review 2.  Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design.

Authors:  Durga Dharmadana; Nicholas P Reynolds; Charlotte E Conn; Céline Valéry
Journal:  Interface Focus       Date:  2017-06-16       Impact factor: 3.906

3.  Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide.

Authors:  Yunxiang Sun; Aleksandr Kakinen; Yanting Xing; Emily H Pilkington; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-11-28       Impact factor: 5.187

4.  Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Authors:  Sanghyun Lee; Xueyun Zheng; Janarthanan Krishnamoorthy; Masha G Savelieff; Hyun Min Park; Jeffrey R Brender; Jin Hoon Kim; Jeffrey S Derrick; Akiko Kochi; Hyuck Jin Lee; Cheal Kim; Ayyalusamy Ramamoorthy; Michael T Bowers; Mi Hee Lim
Journal:  J Am Chem Soc       Date:  2013-12-27       Impact factor: 15.419

Review 5.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

6.  Elongation Factor Tu Switch I Element is a Gate for Aminoacyl-tRNA Selection.

Authors:  Dylan Girodat; Scott C Blanchard; Hans-Joachim Wieden; Karissa Y Sanbonmatsu
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

7.  Mapping the interactions between the Alzheimer's Aβ-peptide and human serum albumin beyond domain resolution.

Authors:  Moustafa Algamal; Julijana Milojevic; Naeimeh Jafari; William Zhang; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

Review 8.  Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Authors:  Hyunbum Jang; Laura Connelly; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Bruce L Kagan; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2013-02-28       Impact factor: 3.676

9.  Insights into antiamyloidogenic properties of the green tea extract (-)-epigallocatechin-3-gallate toward metal-associated amyloid-β species.

Authors:  Suk-Joon Hyung; Alaina S DeToma; Jeffrey R Brender; Sanghyun Lee; Subramanian Vivekanandan; Akiko Kochi; Jung-Suk Choi; Ayyalusamy Ramamoorthy; Brandon T Ruotolo; Mi Hee Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-20       Impact factor: 11.205

Review 10.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease.

Authors:  Samuel A Kotler; Patrick Walsh; Jeffrey R Brender; Ayyalusamy Ramamoorthy
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.